Revenue
No reported data
Alzamend Neuro, Inc. (ALZN)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
2026
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Research & development | $3.6M | $1.4M | $6.5M | $7.4M | $5.2M | $1.3M | $1.1M |
| Operating expenses | $8.8M | $4.5M | $9.9M | $14.9M | — | — | — |
| Operating income | −$8.8M | −$4.5M | −$9.9M | −$14.9M | −$12.3M | −$5.0M | −$4.4M |
| Net income | −$8.8M | −$4.5M | −$9.9M | −$14.9M | −$12.4M | −$5.0M | −$4.4M |
| Basic EPSper diluted share | -$2.63 | -$11.32 | -$132.33 | -$22.89 | -$0.14 | -$0.07 | -$0.06 |
| Diluted EPSper diluted share | -$2.63 | -$11.32 | -$132.33 | -$22.89 | -$0.14 | -$0.07 | -$0.06 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 14, 2026Form 4 | AULT MILTON C IIIDirector | BuyCommon Stock · indirect | 108.4K | $1.00 | $108.4K | 116.6K |
| Dec 23, 2025Form 4 | AULT MILTON C IIIDirector | SellCommon Stock | 1.9K | $2.07 | $3.8K | 0 |
| Dec 19, 2025Form 4 | Horne William B.Director | SellCommon Stock | 3.3K | $2.12 | $7.1K | 0 |
| Oct 23, 2025Form 4 | McGrath Lynne FaheyDirector | SellCommon Stock | 30 | $2.29 | $68.70 | 25 |
| Oct 9, 2025Form 4 | AULT MILTON C IIIDirector | SellCommon Stock · indirect | 20.4K | $2.32 | $47.3K | 8.3K |